Cardiac Safety Research Consortium: Can the thorough QT/QTc study be replaced by early QT assessment in routine clinical pharmacology studies? Scientific update and a research proposal for a path forward

American Heart Journal, September 2014

View Paper Here

Borje Darpo, MD, PhD, Christine Garnett, PharmD, Charles T. Benson, MD, PhD, James Keirns, PhD,  Derek Leishman, PhD, f Marek Malik, MD, PhD, Nitin Mehrotra, PhD, Krishna Prasad, MD, FRCP, Steve Riley, PharmD, PhD, Ignacio Rodriguez, MD, Philip Sager, MD, Nenad Sarapa, MD, and Robert Wallis, PhD  Stockholm, Sweden; Rochester, NY; St Louis, MO; Indianapolis, IN; Northbrook, IL; London, United Kingdom; Silver Spring, MD; Groton, CT; New York, NY; Palo Alto, CA; Inc. Whippany, NJ; and Sandwich, United Kingdom

Centralized adjudication of cardiovascular end points in cardiovascular and noncardiovascular pharmacologic trials: A report from the Cardiac Safety Research Consortium

American Heart Journal, February 2015

View Paper Here

Jonathan H. Seltzer, MD, MBA, MA, a J. Rick Turner, PhD, b Mary Jane Geiger, MD, PhD, c
Giuseppe Rosano, MD, PhD, d Kenneth W. Mahaffey, MD, e William B. White, MD, f Mary Beth Sabol, MD, g Norman Stockbridge, MD, PhD, h and Philip T. Sager, MD i Bala Cynwyd, PA; Durham, NC; Tarrytown, NY; London, UK; Palo Alto, CA; Farmington, CT; Upper Providence, PA; and Silver Spring, MD